92 related articles for article (PubMed ID: 20395112)
21. Dendritic cells in human squamous cell carcinoma of the oral cavity.
Kikuchi K; Kusama K; Taguchi K; Ishikawa F; Okamoto M; Shimada J; Sakashita H; Yamamo Y
Anticancer Res; 2002; 22(2A):545-57. PubMed ID: 12014622
[TBL] [Abstract][Full Text] [Related]
22. Predictive factor for photodynamic therapy effects on oral squamous cell carcinoma and oral epithelial dysplasia.
Uehara M; Ikeda H; Nonaka M; Sumita Y; Nanashima A; Nonaka T; Asahina I
Arch Oral Biol; 2011 Nov; 56(11):1366-72. PubMed ID: 21596370
[TBL] [Abstract][Full Text] [Related]
23. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma.
Cheng CY; Chang CS; Liu CJ; Kao SY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jul; 106(1):79-84. PubMed ID: 18299215
[TBL] [Abstract][Full Text] [Related]
24. [Expression of vascular endothelial growth factor in oral squamous cell carcinoma].
Chen J; Wen Y; Li L; Wang C
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):303-5, 308. PubMed ID: 12539486
[TBL] [Abstract][Full Text] [Related]
25. Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1.
Lissoni P; Malugani F; Bonfanti A; Bucovec R; Secondino S; Brivio F; Ferrari-Bravo A; Ferrante R; Vigoré L; Rovelli F; Mandalà M; Viviani S; Fumagalli L; Gardani GS
J Biol Regul Homeost Agents; 2001; 15(2):140-4. PubMed ID: 11501971
[TBL] [Abstract][Full Text] [Related]
26. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma.
Miyahara M; Tanuma J; Sugihara K; Semba I
Cancer; 2007 Sep; 110(6):1287-94. PubMed ID: 17674352
[TBL] [Abstract][Full Text] [Related]
27. Microvessel density and expression of vascular endothelial growth factor, basic fibroblast growth factor, and platelet-derived endothelial growth factor in oral squamous cell carcinomas.
Li C; Shintani S; Terakado N; Klosek SK; Ishikawa T; Nakashiro K; Hamakawa H
Int J Oral Maxillofac Surg; 2005 Jul; 34(5):559-65. PubMed ID: 16053878
[TBL] [Abstract][Full Text] [Related]
28. [Serum levels of VEGF and nitric oxide in esophageal squamous carcinoma patients and the clinical significance].
Zhang T; Zhang F; Jiang T; Li XF; Wang YJ; Liu K
Ai Zheng; 2002 Nov; 21(11):1248-50. PubMed ID: 12526227
[TBL] [Abstract][Full Text] [Related]
29. Expression of vascular endothelial growth factor and microvessel density in head and neck tumorigenesis.
Tae K; El-Naggar AK; Yoo E; Feng L; Lee JJ; Hong WK; Hittelman WN; Shin DM
Clin Cancer Res; 2000 Jul; 6(7):2821-8. PubMed ID: 10914730
[TBL] [Abstract][Full Text] [Related]
30. The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer.
Inoshima N; Nakanishi Y; Minami T; Izumi M; Takayama K; Yoshino I; Hara N
Clin Cancer Res; 2002 Nov; 8(11):3480-6. PubMed ID: 12429638
[TBL] [Abstract][Full Text] [Related]
31. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
[TBL] [Abstract][Full Text] [Related]
32. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
Harada K; Supriatno ; Yoshida H; Sato M
Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
[TBL] [Abstract][Full Text] [Related]
33. Angiogenesis and the expression of vascular endothelial growth factors A and C in squamous cell carcinoma of the piriform fossa.
Homer JJ; Prentice MG; Cawkwell L; Birchall M; Greenman J; Stafford ND
Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1110-4. PubMed ID: 14568798
[TBL] [Abstract][Full Text] [Related]
34. VEGF and bFGF expression and microvessel density of maxillary sinus squamous cell carcinoma in relation to p53 status, spontaneous apoptosis and prognosis.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Cancer Lett; 2004 May; 208(2):215-25. PubMed ID: 15142681
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte-dendritic cell cross-talk.
Cabillic F; Bouet-Toussaint F; Toutirais O; Rioux-Leclercq N; Fergelot P; de la Pintière CT; Genetet N; Patard JJ; Catros-Quemener V
Clin Exp Immunol; 2006 Dec; 146(3):518-23. PubMed ID: 17100773
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of CD83-positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer.
Tsukayama S; Omura K; Yoshida K; Tanaka Y; Watanabe G
Oncol Rep; 2005 Aug; 14(2):369-75. PubMed ID: 16012717
[TBL] [Abstract][Full Text] [Related]
37. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance.
Salven P; Heikkilä P; Anttonen A; Kajanti M; Joensuu H
Mod Pathol; 1997 Nov; 10(11):1128-33. PubMed ID: 9388064
[TBL] [Abstract][Full Text] [Related]
38. S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Harada K; Supriatno ; Kawashima Y; Yoshida H; Sato M
Int J Oncol; 2007 Feb; 30(2):365-74. PubMed ID: 17203218
[TBL] [Abstract][Full Text] [Related]
39. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
40. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
